Z. Csapo et al., Modulation of human deoxycytidine kinase activity as a response to cellular stress induced by NaF, ACT BIOCH P, 48(1), 2001, pp. 251-256
Deoxycytidine kinase (dCK) is one of the key enzymes of deoxynucleoside sal
vage supplying resting lymphocytes with DNA precursors for synthesis and re
pair. The level of dCK activity is especially important in chemotherapy wit
h the use of deoxynucleoside analogues like arabinosyl cytosine (Citarabid,
ara-C), or 2-chloro-deoxyadenosine (Cladribine, CdA). Previous results sho
wed that Cladribine treatment of human lymphocytes increased several fold t
he activity of dCK without increasing the amount of dCK protein itself (Sas
vari-Szekely, et al., 1998, Biochem. Pharmacol. 56, 1175), and a possible p
ost-translational modification was suggested. This theory was further inves
tigated using NaF as an inhibitor of protein phosphatases. It was shown tha
t NaF treatment of cells elevated dCK activity while inhibiting DNA synthes
is. The possible mechanism of dCK activation/inactivation induced by exposu
re of cell cultures to different agents is discussed.